Telmisartan Market Analysis, Trends, Opportunity, Market Size and Segment Foreca

Posted by Aniket Ankushrao on May 20th, 2019

Global Telmisartan Market: Overview

 

A study shows that the disease burden of hypertension shot up from 87 million in 2000 to little more than 108 million in 2016. Not just that, the average age of a person affected by the condition also dropped from 48.4 to 45.4 during this period. This is a serious indication of how more people, with every year, are falling prey to this lifestyle disease. This, as a result, expands opportunities for drugs to treat hypertension, and one of the prominent brands in the market is Telmisartan.

 

As of now, the global telmisartan market holds a significant position in the market when compared to other competitors. An upcoming Transparency Market Research (TMR) report elucidates on every aspect critical for growth in the global market for telmisartan. The report’s details like key trends, challenges, opportunities, geographical analysis, and competitive dynamics are key for both existing and upcoming players.

 

Global Telmisartan Market: Key Trends

 

Spike in Lifestyle Diseases to Favor Consumption

 

The common term associated with lifestyle today is sedentary. Given the high-pressure work life, and air-conditioned work environments of corporates, the need for people to stay active has reduced drastically. All these aspects collectively instill lifestyle diseases like diabetes, hypertension, and cardiovascular diseases. While lack of activity will increase the chances of the disease, the rising population adapting to smoking and alcohol to destress is expected to spike the incidence of cardiovascular diseases. Telmisartan is used to treat all of these above conditions. With the number of patients increasing, consumption in the global telmisartan market is only expected to increase in the coming years.

 

Rise in Cases of Chronic Kidney Disease

 

About 14% of the world’s population is affected by chronic kidney disease, and research studies show that diabetes and hypertension are the two prime reasons for it. Having said that, telmisartan, has been proven efficient in treating diabetic kidney disease. Studies indicate that the percentage of people suffering from chronic kidney disease will inflate in the coming years, thus spiking demand for telmisartan.

 

Request Brochure of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=65513

 

Global Telmisartan Market: Geographical Analysis

 

Looking at the diseases that telmisartan treats, the market for this drugs is spread across all territories. Based on existing trends and predictions of TMR, North America is expected to hold the highest share in terms of revenue in the global telmisartan market. The rising hypertension and diabetic population in this region, and highly aware consumer base will sustain demand here. Further, Asia Pacific is predicted to emerge in the coming years as a significant proportion of the affected patient population hails from countries here. Also, the growing prominence of the pharmaceutical sector in this part of the world will stimulate demand for telmisartan zin the coming years.

Like it? Share it!


Aniket Ankushrao

About the Author

Aniket Ankushrao
Joined: April 25th, 2019
Articles Posted: 338

More by this author